Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1189/week)
    • Manufacturing(599/week)
    • Technology(1139/week)
    • Energy(398/week)
    • aviation(138/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Mirati Therapeutics, Inc.

Jan 09, 2020
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
Jan 08, 2020
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
Jan 06, 2020
Mirati Therapeutics Announces Executive Management Changes
Nov 04, 2019
Mirati Therapeutics Reports Third Quarter 2019 Financial Results
Oct 23, 2019
Mirati Therapeutics Announces Presentation Of Interim Phase 2 Sitravatinib Data In Urothelial Carcinoma And Oral Cavity Squamous Cell Carcinoma At The SITC 34th Annual Meeting
Oct 17, 2019
Mirati Therapeutics To Present Pre-Clinical And Initial Clinical Data For MRTX849, A KRAS G12C Inhibitor, At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
Aug 15, 2019
Mirati Therapeutics Appoints Jenny Gizzi As Vice President, Human Resources
Aug 05, 2019
Mirati Therapeutics Reports Second Quarter 2019 Financial Results
Jul 09, 2019
Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155
Jun 27, 2019
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
Jun 25, 2019
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
Jun 24, 2019
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
Apr 29, 2019
Mirati Therapeutics Reports First Quarter 2019 Financial Results
Apr 01, 2019
Mirati Therapeutics To Present At The H.C. Wainwright & Co. Global Life Sciences Conference
Feb 07, 2019
Mirati Therapeutics To Present At The Guggenheim Healthcare Talks Idea Forum & Oncology Day
Jan 22, 2019
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
Jan 16, 2019
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
Jan 16, 2019
Mirati Therapeutics Announces Proposed Public Offering Of Common Stock
Jan 15, 2019
Mirati Therapeutics Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of MRTX849, A Novel KRAS G12C Inhibitor
Jan 07, 2019
Mirati Announces Clinical Collaboration With Bristol-Myers Squibb For The Planned Phase 3 Trial In Non-Small Cell Lung Cancer To Evaluate Sitravatinib In Combination With Nivolumab (OPDIVO®)
  • ‹‹
  • Page 2
  • ››

Latest News

Jun 15, 2025

Toddler among seven killed in India chopper crash

Jun 15, 2025

Families hold funerals for Air India crash victims

Jun 15, 2025

G7: l'Australie veut aborder les surtaxes douanières et l'avenir de l'Aukus avec Washington

Jun 15, 2025

Israeli military says hit Iran defence ministry HQ, nuclear weapons-linked sites

Jun 15, 2025

Boeing 20-Year Forecast Shows Steady Demand for Nearly 44,000 New Airplanes

Jun 14, 2025

Gold Road Inc. Acquires Arizona Gold Mine, Upsizes Financing to C$3M, Welcomes Former Central Bank Governor...

Jun 14, 2025

President Trump Approves Historic Partnership between U. S. Steel and Nippon Steel

Jun 14, 2025

Federal Court in Delaware Dismisses Antitrust Challenge to Wabtec-GE Transportation Merger

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia